Major adverse cardiovascular events in Survivors of Immune-mediated Thrombotic Thrombocytopenic Purpura.
Sign Up to like & getrecommendations! Published in 2021 at "American journal of hematology"
DOI: 10.1002/ajh.26341
Abstract: Cardiovascular disease is a leading cause of death in survivors of immune-mediated thrombotic thrombocytopenic purpura (iTTP), but the epidemiology of major adverse cardiovascular events (MACE) in iTTP survivors is unknown. We evaluated the prevalence and… read more here.
Keywords: survivors immune; thrombotic thrombocytopenic; immune mediated; major adverse ... See more keywords